3
Announcements
Trials
Browse
Landscape
Sponsor
Interventions
TIC10 compound
3
trastuzumab deruxtecan
2
umbralisib
1
ublituximab
1
pembrolizumab
1
infigratinib
1
enfortumab vedotin
1
duvelisib
1
blinatumomab
1
belumosudil
1
Rituximab
1
KD025
1
Gemcitabine
1
Crizotinib
1
Cisplatin
1
Carboplatin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Terminated
×
Has announcements
×
National Cancer Institute (U.S.)
×
Clear all
No trials found.